Dyadic to Attend Industry Events in April
27 mars 2024 08h30 HE
|
Dyadic International, Inc.
JUPITER, Fla., March 27, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...
Animal Biotechnology Market Report 2024-2029, Featuring Profiles of Zeus Biotech, Invetx, Ingenta Connect, Kingfisher Biotech, Animab, Boehringer Ingelheim, RSPCA, Santa Cruz Biotechnology and Pfizer
20 mars 2024 13h37 HE
|
Research and Markets
Dublin, March 20, 2024 (GLOBE NEWSWIRE) -- The "Animal Biotechnology Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering.The animal biotechnology market...
Dyadic to Report Full Year 2023 Financial Results and Host Conference call on Thursday, March 28, 2024
14 mars 2024 16h30 HE
|
Dyadic International, Inc.
JUPITER, Fla., March 14, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused building...
Global Syndromic Multiplex Panels Market Set for Rapid Expansion, Reveals New 2024-2028 Sector Forecast
12 mars 2024 11h23 HE
|
Research and Markets
Dublin, March 12, 2024 (GLOBE NEWSWIRE) -- The "Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, GI etc.) by Place, by Product and by Country....
Industry Orgs Applaud Bill to Boost Bars, Restaurants and Venues with Draft Systems
11 mars 2024 14h21 HE
|
Beer Institute
WASHINGTON, March 11, 2024 (GLOBE NEWSWIRE) -- Today, the Beer Institute, the oldest national trade association representing the beer industry, released the following statement after Reps. Darin...
Asia-Pacific's Next-Generation IVD Market Worth $42+ Billion by 2033: Key Insights by Type, End-user and Country
08 mars 2024 10h04 HE
|
Research and Markets
Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Asia-Pacific Next-Generation IVD Market: Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering.The...
United States Medical Diagnostics Analysis Report 2024-2028: Growing Burden of Chronic Diseases, Escalating Use of EHR Systems and Rising Healthcare Expenditure Driving Growth
07 mars 2024 05h51 HE
|
Research and Markets
Dublin, March 07, 2024 (GLOBE NEWSWIRE) -- The "US Medical Diagnostics Market (Product Type, End-User & Region): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)" report has...
Europe Medical Diagnostics Analysis Report 2024: A $109.91 Billion Market by 2028 with Focus on Immunoassays, Clinical Chemistry, Haematology & Coagulation
07 mars 2024 05h20 HE
|
Research and Markets
Dublin, March 07, 2024 (GLOBE NEWSWIRE) -- The "Europe Medical Diagnostics Market (Immunoassays, Clinical Chemistry, Haematology & Coagulation): Insights & Forecast with Potential Impact of...
Global COVID-19 Diagnostics Market Research Report 2024
29 févr. 2024 04h40 HE
|
Research and Markets
Dublin, Feb. 29, 2024 (GLOBE NEWSWIRE) -- The "Global COVID-19 Diagnostics Market Forecast by Technology, Product, Channel and Country: Assay Volumes and 5-Year Market Size Outlook" report has been...
BioAegis Therapeutics Unveils Upcoming Clinical Study of Gelsolin, an Immune Regulator, as a Treatment for Patients with Acute Respiratory Distress Syndrome (ARDS)
27 févr. 2024 15h52 HE
|
BioAegis Therapeutics
BioAegis announces global Phase 2 study of its inflammation regulator protein, gelsolin, for the treatment of Acute Respiratory Distress Syndrome (ARDS).